Clinical Trial Update: Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating renal tubular injury and transplant outcomes when converting from IR tacrolimus to XR tacrolimus in cardiac transplant recipie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Transplant

Drugs mentioned

• IR tacrolimus (tacrolimus (immediate-release))
• XR tacrolimus (tacrolimus (XR formulation))

Snippet

Sponsor: Loyola University | Conditions: Chronic Kidney Diseases, Heart Transplant | Phase 4 | Status: UNKNOWN